[← 返回 README](../README.md)

# 5. Conclusion

## 📌 Preview

HistoSelect addresses explainability and redundancy in pathology VQA by mimicking the coarse-to-fine diagnostic strategy of pathologists. The question-aware hierarchical selection framework efficiently prunes irrelevant patches, increases signal-to-noise ratio, and provides transparent visual evidence. Extensive experiments and pathologist evaluations confirm SOTA performance and clinical trustworthiness. Limitations include limited dataset diversity and the lack of explicit textual reasoning, pointing to future directions.

---

In this work, we introduce HistoSelect, a question-aware framework addressing explainability and redundancy in current pathology VQA models. By mimicking the coarse-to-fine diagnostic strategy of human pathologists, HistoSelect efficiently prunes question-irrelevant patches, thereby increasing the signal-to-noise ratio for the downstream MLLM. This targeted selection process provides transparent and attributable visual evidence for prediction. Extensive experiments across diverse datasets, complemented by rigorous evaluations from practicing pathologists, confirm that HistoSelect not only achieves state-of-the-art performance but also delivers the trustworthy, explainable reasoning necessary to bridge the gap between automated analysis and clinical adoption in computational pathology.

> 💡 **Q&A 批注记录**:
>
> **Q**: 这篇论文最重要的贡献是什么？
>
> **A**: 最重要的贡献不是 SOTA 性能本身（虽然确实达到了），而是提出了一个**可解释的、问题引导的层级选择框架**。具体来说：(1) 从病理学家的实际工作流出发的"粗到细"选择范式；(2) 基于 IB 理论的形式化层级压缩目标；(3) 将组织分割（粗粒度结构）与问题引导选择（细粒度筛选）结合的完整 pipeline。这些为构建"更像病理学家"的 AI 诊断助手提供了理论和实践基础。

> **Q**: 论文的方法是否可以推广到其他领域？
>
> **A**: 潜在的推广方向：任何涉及"大输入空间 + 具体问题"的场景，如卫星图像分析、长视频理解、大规模文档检索等。关键是：(1) 输入空间可被分割为语义上有意义的组（如组织类型→文档主题），(2) 每个具体问题只与一部分信息相关，(3) 存在一个可学习的问题-信息相关性度量。层级 IB 框架本身是领域无关的，但组织分割的 CLIP 风格设计需要领域特定的 prompt 设计。

---

## Limitations and Future Work (from Supplementary)

While our proposed method demonstrates promising results and improved efficiency in histopathology VQA, we acknowledge several limitations that outline directions for future research.

**Evaluation on Other Datasets.** First, our current experimental validation primarily focuses on the TCGA dataset and our in-house private dataset. While this covers a significant amount of variation, the heterogeneity of pathological data across different organs and scanning protocols is vast. To further verify the generalizability of our model, we intend to extend our training and testing to other large-scale public datasets, such as the BCNB (Early Breast Cancer Core-Needle Biopsy) [43] dataset. Evaluating on such diverse cohorts will help ensure our method remains robust across different cancer subtypes and data distributions.

**Lack of Explicit Textual Reasoning.** Second, while our method offers visual interpretability by highlighting the selected question-relevant patches, it does not currently generate explicit textual explanations justifying why these patches were selected. Providing a natural language rationale alongside the final VQA answer would further enhance trust in clinical decision-support systems. We aim to explore the integration of LLMs more deeply in future iterations to bridge this gap between visual attention and semantic reasoning.

> 💡 **Q&A 批注记录**:
>
> **Q**: 论文最大的局限是什么？
>
> **A**: 我认为有两个：
> 1. **数据集多样性的局限**：目前仅在 TCGA 和一个小规模的卵巢癌数据集上验证。不同器官的病理切片在染色、组织结构、病变模式上差异巨大，HistoSelect 的组织分割 prompt 和选择策略能否泛化到这些场景是未验证的。
> 2. **缺乏文本层面的可解释性**：模型能展示"选了哪些补丁"，但不能生成自然语言解释"为什么选这些补丁"。这对临床采纳是一个障碍——病理学家不仅需要看到证据，还需要理解模型对证据的解读逻辑。
>
> 另外，还有一个潜在的局限论文未提及：**组织分割的质量天花板**。组织分割是零样本 CLIP 风格匹配，其精度受限于 (1) CONCH 编码器的质量，(2) 人工设计的 prompt 的覆盖度。如果某个组织类型没有被 prompt 覆盖，它会被错误分类，进而影响下游选择。

## 🔖 Summary

HistoSelect introduces a hierarchical, question-guided patch selection framework for pathology VQA that mimics pathologists' coarse-to-fine diagnostic workflow. Key contributions include pathologist-defined tissue prompts, an IB-grounded dual-level compression objective, and rigorous clinical validation. The method achieves SOTA while reducing tokens by 70%. Future directions include broader dataset validation, explicit textual reasoning, and further development of the group selection mechanism for complex multi-tissue reasoning.
